Nxera Pharma Co., Ltd.【JP:4565】Balance sheet

Market cap

¥78.2B

P/E ratio

	2014/03	2015/03	2016/03	2017/03	2018/03	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	-	2,495	6,945	1,488	22,421	16,511	15,375	40,008	60,087	66,557	49,065	32,268
Marketable securities, current	-	-	-	-	-	-	-	-	86	-	316	-
Accounts receivable, net	-	-	-	-	-	987	1,924	939	2,138	2,462	5,064	6,695
Inventories	-	-	-	-	-	-	-	-	-	32	2,903	8,838
Total current assets	-	2,761	7,447	2,972	24,211	21,530	19,563	42,018	62,808	69,942	65,112	57,855
Property, plant and equipment, net	-	6	5	4	86	81	4,120	3,824	3,817	3,791	7,900	7,468
Marketable securities, non-current	-	-	-	-	-	1,515	2,053	1,593	2,564	1,737	3,266	4,518
Total non-current assets	-	45,442	41,242	45,179	45,447	44,888	37,117	34,447	34,177	29,475	92,086	93,643
Total assets	-	48,203	48,690	48,151	69,658	58,987	56,680	76,465	96,985	99,417	157,198	151,498
Accounts payable	-	-	-	-	-	2,080	1,211	1,508	1,176	1,628	4,244	4,052
Short-term debt	-	20,000	-	-	-	-	-	-	-	36	-	-
Long-term debt, current	-	-	2,000	2,000	3,000	3,000	175	-	-	-	5,800	5,800
Total current liabilities	-	20,722	2,407	2,293	3,650	4,620	2,303	2,985	7,191	4,092	17,185	15,632
Long-term debt, non-current	-	-	7,000	5,000	6,250	7,970	3,408	1,664	1,638	1,577	36,735	30,433
Total non-current liabilities	-	-	7,000	5,022	6,314	4,051	9,299	21,099	32,326	37,389	73,203	67,348
Total liabilities	-	20,722	9,407	7,315	9,965	17,407	11,602	24,084	39,517	41,481	90,388	82,980
Common stock and paid-in capital	-	27,072	40,027	40,125	61,681	124,721	127,102	139,229	140,325	141,647	162,586	164,707
Retained earnings	-	233	-1,052	-48	-3,410	-5,911	-12,264	-10,785	-9,768	-8,911	-16,104	-20,942
Stockholders' equity	27,224	27,481	39,283	40,835	59,693	57,747	45,078	52,381	57,468	57,936	66,810	68,518